Schedule 13G/A

SLNOEUR Schedule 13G/A filing by Fidelity / FMR

Fidelity / FMR reported beneficial ownership of 193 shares, representing 12% of SOLENO THERAPEUTICS INC in this filing.

FiledMay 7, 2026

Ownership dateApr 30, 2026

Reported shares193

Reported ownership12%

Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 192.7K

Shared voting power 193

Sole dispositive power 193

Shared dispositive power 193

Compared with the prior filing

How the reported position changed

This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for SLNOEUR. A change between filings does not by itself establish when shares were bought or sold.

Previous filingMay 6, 2026

Reported share change-5,575

Ownership percentage change0 pts

	Previous filing	This filing
Reported shares	5.8K	193
Reported ownership	12%	12%

Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer: Fidelity / FMR
CIK: CIK0000315066
Accession: 0000315066-26-001372
Form: Schedule 13G/A

Open SEC filing View SLNOEUR ownership history

Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →